Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 421.25 DKK -1.03%
Market Cap: 1.9T DKK
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
Growth Rates:
1 Year
+25%
3 Years
+106%
5 Years
+138%
7 Years
+160%
10 Years
+227%
0
Operating Income
+0%
Growth Rates:
1 Year
+33%
3 Years
+134%
5 Years
+159%
7 Years
+182%
10 Years
+303%
0
Net Income
+0%
Growth Rates:
1 Year
+21%
3 Years
+111%
5 Years
+159%
7 Years
+165%
10 Years
+281%

Earnings Waterfall
Novo Nordisk A/S

Revenue
290.4B DKK
Cost of Revenue
-43.6B DKK
Gross Profit
246.8B DKK
Operating Expenses
-107.9B DKK
Operating Income
138.9B DKK
Other Expenses
-37.9B DKK
Net Income
101B DKK

Income Statement
Novo Nordisk A/S

Rotate your device to view
Income Statement
Currency: DKK
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024
Revenue
Revenue
88 806
N/A
93 663
+5%
99 093
+6%
103 636
+5%
107 927
+4%
109 939
+2%
110 339
+0%
111 084
+1%
111 780
+1%
113 020
+1%
114 199
+1%
113 276
-1%
111 696
-1%
110 174
-1%
108 943
-1%
110 091
+1%
111 831
+2%
114 192
+2%
116 821
+2%
119 336
+2%
122 021
+2%
126 605
+4%
126 575
0%
127 225
+1%
126 946
0%
126 875
0%
129 910
+2%
134 605
+4%
140 800
+5%
149 027
+6%
157 251
+6%
167 195
+6%
176 954
+6%
188 290
+6%
201 325
+7%
214 490
+7%
232 261
+8%
244 243
+5%
258 003
+6%
270 583
+5%
290 403
+7%
Gross Profit
Cost of Revenue
(14 562)
(14 970)
(15 158)
(15 579)
(16 188)
(16 548)
(16 734)
(16 873)
(17 183)
(17 200)
(17 564)
(17 850)
(17 632)
(17 578)
(17 521)
(17 664)
(17 617)
(18 152)
(18 649)
(19 309)
(19 559)
(20 742)
(20 665)
(20 745)
(20 932)
(21 357)
(22 132)
(23 036)
(23 658)
(24 764)
(25 286)
(26 427)
(28 448)
(29 713)
(31 500)
(34 013)
(35 765)
(37 499)
(39 917)
(41 512)
(43 560)
Gross Profit
74 244
N/A
78 693
+6%
83 935
+7%
88 057
+5%
91 739
+4%
93 391
+2%
93 605
+0%
94 211
+1%
94 597
+0%
95 820
+1%
96 635
+1%
95 426
-1%
94 064
-1%
92 596
-2%
91 422
-1%
92 427
+1%
94 214
+2%
96 040
+2%
98 172
+2%
100 027
+2%
102 462
+2%
105 863
+3%
105 910
+0%
106 480
+1%
106 014
0%
105 518
0%
107 778
+2%
111 569
+4%
117 142
+5%
124 263
+6%
131 965
+6%
140 768
+7%
148 506
+5%
158 577
+7%
169 825
+7%
180 477
+6%
196 496
+9%
206 744
+5%
218 086
+5%
229 071
+5%
246 843
+8%
Operating Income
Operating Expenses
(39 752)
(40 753)
(42 246)
(42 957)
(44 780)
(45 944)
(46 143)
(46 309)
(45 623)
(46 207)
(46 133)
(45 300)
(44 785)
(44 793)
(44 679)
(45 915)
(46 972)
(47 001)
(47 885)
(48 634)
(48 779)
(51 317)
(50 978)
(51 659)
(51 411)
(52 712)
(54 031)
(55 381)
(57 784)
(61 454)
(65 544)
(69 412)
(72 837)
(77 908)
(83 659)
(87 582)
(91 798)
(97 331)
(100 927)
(110 703)
(107 942)
Selling, General & Administrative
(26 760)
(27 870)
(29 578)
(30 712)
(32 691)
(32 817)
(32 495)
(32 467)
(32 630)
(32 390)
(32 268)
(31 786)
(32 384)
(31 739)
(32 062)
(32 729)
(33 656)
(33 855)
(34 346)
(35 056)
(35 301)
(36 490)
(36 283)
(36 693)
(36 108)
(37 557)
(38 237)
(39 200)
(40 409)
(43 023)
(45 949)
(48 415)
(49 932)
(53 014)
(56 597)
(58 063)
(60 767)
(62 528)
(63 205)
(65 722)
(66 546)
Research & Development
(13 762)
(13 844)
(13 804)
(13 439)
(12 936)
(13 662)
(13 958)
(14 127)
(13 643)
(14 548)
(14 631)
(14 501)
(13 278)
(14 046)
(13 928)
(14 244)
(13 568)
(14 162)
(14 423)
(14 380)
(13 477)
(15 319)
(15 053)
(15 363)
(13 713)
(15 629)
(16 282)
(16 623)
(16 292)
(19 034)
(20 213)
(21 594)
(21 761)
(25 569)
(27 573)
(30 068)
(29 373)
(34 321)
(37 660)
(39 020)
(38 021)
Depreciation & Amortization
0
0
0
0
(484)
0
0
0
(513)
0
0
0
(586)
0
0
0
(1 289)
0
0
0
(856)
0
0
0
(2 178)
0
0
0
(1 631)
0
0
0
(2 478)
0
0
0
(2 339)
0
0
0
(3 346)
Other Operating Expenses
770
961
1 136
1 194
1 331
535
310
285
1 163
731
766
987
1 463
992
1 311
1 058
1 541
1 016
884
802
855
492
358
397
588
474
488
442
548
603
618
597
1 334
675
511
549
681
(482)
(62)
(5 961)
(29)
Operating Income
34 492
N/A
37 940
+10%
41 689
+10%
45 100
+8%
46 959
+4%
47 447
+1%
47 462
+0%
47 902
+1%
48 974
+2%
49 613
+1%
50 502
+2%
50 126
-1%
49 279
-2%
47 803
-3%
46 743
-2%
46 512
0%
47 242
+2%
49 039
+4%
50 287
+3%
51 393
+2%
53 683
+4%
54 546
+2%
54 932
+1%
54 821
0%
54 603
0%
52 806
-3%
53 747
+2%
56 188
+5%
59 358
+6%
62 809
+6%
66 421
+6%
71 356
+7%
75 669
+6%
80 669
+7%
86 166
+7%
92 895
+8%
104 698
+13%
109 413
+5%
117 159
+7%
118 368
+1%
138 901
+17%
Pre-Tax Income
Interest Income Expense
(396)
(2 036)
(4 226)
(5 955)
(5 880)
(4 945)
(2 906)
(1 181)
(549)
(764)
(1 612)
(1 075)
(219)
1 360
2 397
1 304
439
(1 811)
(3 412)
(3 549)
(3 757)
(4 194)
(3 309)
(2 614)
(846)
1 241
1 801
1 781
558
(1 748)
(3 482)
(5 497)
(5 566)
(4 789)
(2 827)
475
2 297
2 442
1 474
886
(859)
Non-Reccuring Items
0
2 376
2 376
2 376
2 485
449
449
449
(542)
0
0
0
(312)
122
0
0
6
0
0
0
(1 200)
0
0
0
(477)
0
0
0
(714)
0
0
0
(860)
0
0
0
(2 124)
0
(5 700)
0
(10 562)
Total Other Income
0
0
0
0
(81)
0
0
0
(85)
0
0
0
(68)
0
0
0
(72)
0
0
0
(173)
0
0
0
(150)
0
0
0
(122)
0
0
0
(181)
0
0
0
(197)
0
0
0
(289)
Pre-Tax Income
34 096
N/A
38 280
+12%
39 839
+4%
41 521
+4%
43 483
+5%
42 951
-1%
45 005
+5%
47 170
+5%
47 798
+1%
48 849
+2%
48 890
+0%
49 051
+0%
48 680
-1%
49 285
+1%
49 140
0%
47 816
-3%
47 615
0%
47 228
-1%
46 875
-1%
47 844
+2%
48 553
+1%
50 352
+4%
51 623
+3%
52 207
+1%
53 130
+2%
54 047
+2%
55 548
+3%
57 969
+4%
59 080
+2%
61 061
+3%
62 939
+3%
65 859
+5%
69 062
+5%
75 880
+10%
83 339
+10%
93 370
+12%
104 674
+12%
111 855
+7%
112 933
+1%
119 254
+6%
127 191
+7%
Net Income
Tax Provision
(7 615)
(8 381)
(8 591)
(8 390)
(8 623)
(8 512)
(8 941)
(9 686)
(9 873)
(10 223)
(10 281)
(10 475)
(10 550)
(10 560)
(10 023)
(9 432)
(8 987)
(8 906)
(9 301)
(9 113)
(9 602)
(9 949)
(10 190)
(10 670)
(10 992)
(11 183)
(11 186)
(11 786)
(11 323)
(11 717)
(12 400)
(13 034)
(13 537)
(14 751)
(16 100)
(18 058)
(20 991)
(22 579)
(23 035)
(24 533)
(26 203)
Income from Continuing Operations
26 481
29 899
31 248
33 131
34 860
34 439
36 064
37 484
37 925
38 626
38 609
38 576
38 130
38 725
39 117
38 384
38 628
38 322
37 574
38 731
38 951
40 403
41 433
41 537
42 138
42 864
44 362
46 183
47 757
49 344
50 539
52 825
55 525
61 129
67 239
75 312
83 683
89 276
89 898
94 721
100 988
Net Income (Common)
26 481
N/A
29 899
+13%
31 248
+5%
33 131
+6%
34 860
+5%
34 439
-1%
36 064
+5%
37 484
+4%
37 925
+1%
38 626
+2%
38 609
0%
38 576
0%
38 130
-1%
38 725
+2%
39 117
+1%
38 384
-2%
38 628
+1%
38 322
-1%
37 574
-2%
38 731
+3%
38 951
+1%
40 403
+4%
41 433
+3%
41 537
+0%
42 138
+1%
42 864
+2%
44 362
+3%
46 183
+4%
47 757
+3%
49 344
+3%
50 539
+2%
52 825
+5%
55 525
+5%
61 129
+10%
67 239
+10%
75 312
+12%
83 683
+11%
89 276
+7%
89 898
+1%
94 721
+5%
100 988
+7%
EPS (Diluted)
5.02
N/A
5.74
+14%
6.04
+5%
6.44
+7%
6.76
+5%
6.75
0%
7.09
+5%
7.4
+4%
7.48
+1%
7.72
+3%
7.77
+1%
7.81
+1%
7.69
-2%
7.92
+3%
8.04
+2%
7.93
-1%
7.97
+1%
8
+0%
7.88
-2%
8.16
+4%
8.19
+0%
8.57
+5%
8.85
+3%
8.89
+0%
9
+1%
9.25
+3%
9.61
+4%
10.05
+5%
10.37
+3%
10.8
+4%
11.1
+3%
11.64
+5%
12.22
+5%
13.54
+11%
14.93
+10%
16.77
+12%
18.62
+11%
19.95
+7%
20.13
+1%
21.23
+5%
22.63
+7%

See Also

Summary
NOVO B intrinsic value, competitors valuation, and company profile.
DCF Valuation
NOVO B stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NOVO B stock valuation using valuation multiples.
Wall Street Estimates
NOVO B price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NOVO B stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 247,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.